CD274 and neoplasm: Indeed, C57BL/6 mice with LCMV memory concurrently treated with NDV-GP and PD-L1 ICB demonstrated ~60% complete protection against MC38 tumor challenge, which was superior to treatment with NDV-GP or PD-L1 ICB therapy alone (Fig. 7a,b).